Supernus Pharmaceuticals shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Supernus Pharmaceuticals (SUPN) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Supernus Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Supernus Pharmaceuticals held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Supernus Pharmaceuticals by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $8.2M | 171k | 47.79 |
| 2025-03-31 | $17M | 509k | 32.76 |
| 2024-12-31 | $11M | 298k | 36.15 |
| 2024-09-30 | $7.9M | 253k | 31.18 |
| 2024-06-30 | $4.8M | 180k | 26.76 |
| 2024-03-31 | $6.7M | 197k | 34.12 |
| 2023-12-31 | $4.5M | 156k | 28.94 |
| 2023-09-30 | $3.7M | 134k | 27.57 |
| 2023-06-30 | $4.3M | 142k | 30.06 |
| 2023-03-31 | $6.5M | 147k | 44.07 |
| 2022-12-31 | $8.7M | 243k | 35.66 |
| 2022-06-30 | $7.3M | 253k | 28.92 |
| 2022-03-31 | $2.3M | 71k | 32.31 |
| 2021-12-31 | $0 | 60k | 0.00 |
| 2021-03-31 | $1.3M | 49k | 26.18 |
| 2020-12-31 | $1.8M | 70k | 25.16 |
| 2020-09-30 | $792k | 38k | 20.84 |
| 2020-06-30 | $1.0M | 44k | 23.35 |
| 2020-03-31 | $669k | 37k | 17.98 |
| 2019-12-31 | $946k | 40k | 23.73 |
| 2019-09-30 | $511k | 19k | 27.46 |
| 2019-06-30 | $522k | 16k | 31.85 |
| 2019-03-31 | $495k | 14k | 35.29 |
| 2018-12-31 | $1.7M | 52k | 33.22 |
| 2018-09-30 | $7.2M | 143k | 50.35 |
| 2018-06-30 | $12M | 199k | 59.85 |
| 2018-03-31 | $21M | 462k | 45.76 |
| 2017-12-31 | $7.1M | 174k | 41.18 |
| 2017-06-30 | $2.3M | 52k | 44.12 |
| 2017-03-31 | $2.3M | 77k | 29.41 |
| 2016-12-31 | $2.8M | 94k | 29.41 |
| 2016-09-30 | $654k | 27k | 24.71 |
| 2016-06-30 | $2.0k | 85 | 23.53 |
| 2016-03-31 | $2.9M | 188k | 15.25 |
| 2015-12-31 | $2.5M | 188k | 13.44 |